Frenel JS, Lusque A, Delaloge S, Ferrero JM, et al. Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation. Br J Cancer 2023 Apr 3. doi: 10.1038/s41416-023-02248.
PMID: 37012318